9th December 2025

Can Viagra (Sildenafil) Help With Alzheimer's

By Mr Suhail Jamil

Trustpilot

Can Viagra (Sildenafil) Help With Alzheimer's

Across the UK, Viagra (sildenafil) is widely recognized as a popular treatment for erectile dysfunction. Since its introduction in the late 1990s, it has become a well-known medication that has helped millions of men manage sexual health issues effectively. However, recent discoveries suggest that the famous “little blue pill” may have benefits beyond its traditional use.

New research from University College London indicates that Sildenafil could play a role in combating certain illnesses, including neurodegenerative conditions such as Alzheimer’s disease. This has sparked growing interest within the medical community, prompting scientists to explore how the drug might influence brain health. This article will delve into recent studies, the scientific mechanisms behind these findings, and expert perspectives on this emerging area of research.

Viagra and Alzheimer’s

There has been recent interest in whether Viagra (sildenafil) could also be a treatment for Alzheimer’s disease. Sildenafil may also assist in boosting blood flow to the brain, maintaining healthy cognitive function.

Additionally, large-scale observational studies have discovered some possible associations between the regular use of Sildenafil and lowered risk of developing Alzheimer’s. These findings are promising, but scientists emphasize that more thorough clinical trials are required to fully determine whether Viagra is actually effective and safe for treating or preventing this complicated neurodegenerative condition.

Studies About Viagra and Brain Health

Over the last few years, scientists have explored the relationship between Viagra (sildenafil) and the brain, specifically as a possible treatment for Alzheimer's disease. A 2021 study also noted that Sildenafil users had a very high rate reduction — up to 69 percent of developing Alzheimer's disease as compared to non-users. Moreover, researchers also suggest that sildenafil may contribute to brain health by reducing inflammation and enhancing blood flow.

A five year study looking at medical records of 270,000 men with ED found that those taking Sildenafil or any other PDE5 inhibitor were 18% less likely to develop Alzheimer’s disease as compared to those who did not take any drugs. The correlation was the strongest with those who had the most prescriptions for the medication.

However, a new study who aimed to verify these findings of the earlier study found no sifnigiicajt correlations. As most people take Sildenafil for ED, they believed this created differences in the two groups being studied for Alzheimer's. The newer study used all patients treated with Sildenafil or Tadalafil for pulmonary arterial hypertension.

The control group was treated for pulmonary arterial hypertension with a different drug, not a PDE5 inhibitor. This ensured the characteristics of both groups remained similar, removing any potential bias as with the first study. There was no significant different in AD and related dementia incidences between the two groups. They also examined the effects of Sildenafil on the molecular features of alzheimers. Although, sildenafil did have some anti-inflammatory effect, no protective effects were seen.